Skip to main content

Peer Review reports

From: Natalizumab administration in multiple sclerosis patients during active SARS-CoV-2 infection: a case series

Original Submission
27 Jul 2021 Submitted Original manuscript
12 Aug 2021 Reviewed Reviewer Report
18 Aug 2021 Reviewed Reviewer Report
22 Aug 2021 Author responded Author comments - Clara Grazia Chisari
Resubmission - Version 2
22 Aug 2021 Submitted Manuscript version 2
23 Aug 2021 Reviewed Reviewer Report
20 Sep 2021 Reviewed Reviewer Report
23 Sep 2021 Author responded Author comments - Clara Grazia Chisari
Resubmission - Version 3
23 Sep 2021 Submitted Manuscript version 3
Publishing
29 Sep 2021 Editorially accepted
29 Nov 2021 Article published 10.1186/s12883-021-02421-3

You can find further information about peer review here.

Back to article page